Form 8-K ZS Pharma, Inc. For: Nov 10
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
ZS Pharma (ZSPH) Misses Q3 EPS by 7c
November 10, 2014 5:03 PM ESTZS Pharma (NASDAQ: ZSPH) reported Q3 EPS of ($0.81), $0.07 worse than the analyst estimate of ($0.74).
For earnings history and earnings-related data on ZS Pharma (ZSPH) click here.
... More